Skin and Soft Tissue Infection Treatment and Prevention Practices by Pediatric Infectious Diseases Providers

Katelyn L Parrish; Noble K Salwan; Ryley M Thompson; Patrick G Hogan; Rachel C Orscheln; Jason G Newland; Stephanie A Fritz

doi:10.1093/jpids/piz080

Skin and Soft Tissue Infection Treatment and Prevention Practices by Pediatric Infectious Diseases Providers

J Pediatric Infect Dis Soc. 2020 Dec 31;9(6):760-765. doi: 10.1093/jpids/piz080.

Authors

Katelyn L Parrish¹, Noble K Salwan¹, Ryley M Thompson¹, Patrick G Hogan¹, Rachel C Orscheln¹, Jason G Newland¹, Stephanie A Fritz¹

Affiliation

¹ Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri, USA.

Abstract

We surveyed 323 members of the Pediatric Infectious Diseases Society about their clinical practices for skin abscess management based on the 2011 Infectious Diseases Society of America guidelines and contemporary evidence. Despite this guideline and recent randomized trials, variability exists among pediatric infectious diseases clinicians in current skin and soft tissue infection management practices.

Keywords: Staphylococcus aureus; SSTI management; antibiotics; decolonization; skin and soft tissue infection.

© The Author(s) 2019. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

MeSH terms

Abscess / drug therapy
Anti-Bacterial Agents / therapeutic use
Child
Communicable Diseases* / drug therapy
Humans
Methicillin-Resistant Staphylococcus aureus*
Soft Tissue Infections* / drug therapy
Soft Tissue Infections* / prevention & control
Staphylococcal Skin Infections*

Substances

Anti-Bacterial Agents